AI-assisted diagnosis for early breast cancer
Part of Cancer, Skin clinical trials.
This trial uses artificial intelligence (AI) to help doctors more accurately identify early-stage breast cancer from test results. It could lead to faster and more precise diagnosis, which may help you get the right treatment sooner.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had a breast lump or mass that was tested (biopsy) and the results are available.
- You have been diagnosed with breast cancer or your doctor has ruled out breast cancer based on your biopsy.
- You do not have any mental health conditions that would interfere with participation.
- You do not have breast implants.
- You are not pregnant or breastfeeding.
- You have not had surgery or radiation/chemotherapy for a non-breast condition during the study period.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an artificial intelligence (AI) model that looks at pictures of breast tissue to find cancer. It may help improve early detection and reduce the need for invasive tests.
This study tests whether artificial intelligence (AI) can improve breast cancer screening in women. It may help find cancer earlier and more accurately.
This study uses artificial intelligence to look at chest CT scans taken during routine health check-ups to find early signs of breast cancer. It may help improve early detection without extra scans.
This study tests whether artificial intelligence (AI) can help radiologists read mammograms (breast X-rays) more accurately during routine breast cancer screening. It aims to see if AI can catch more cancers early while reducing unnecessary follow-up exams.
This trial uses artificial intelligence to analyze images of your tumor tissue to predict if breast cancer might spread to other parts of the body. It may help doctors better understand your individual risk and guide treatment decisions.
This study tests whether an AI tool can predict how well breast cancer responds to chemotherapy given before surgery. Your tumor sample from a needle biopsy will be analyzed to see if the AI's prediction matches your actual treatment outcome.
Hear when a new Artifical Intelligence trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.